CN Patent

CN103052392A — 通过氨基糖苷气雾给药治疗肺部感染

Assigned to Xellia Pharmaceuticals ApS · Expires 2013-04-17 · 13y expired

What this patent protects

本发明提供一种新的给药方式和新的给药方案，用于治疗或防治患者肺部系统细菌感染，尤其提供一种用于高浓度氨基糖苷（例如妥布霉素）气雾化的组合物。

USPTO Abstract

本发明提供一种新的给药方式和新的给药方案，用于治疗或防治患者肺部系统细菌感染，尤其提供一种用于高浓度氨基糖苷（例如妥布霉素）气雾化的组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN103052392A
Jurisdiction
CN
Classification
—
Expires
2013-04-17
Drug substance claim
No
Drug product claim
No
Assignee
Xellia Pharmaceuticals ApS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.